We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Terason Partners With Aloka for European Market

By HospiMedica staff writers
Posted on 16 Nov 2005
Print article
Terason (Burlington, MA, USA; www.terason.com), a leading developer of high-performance laptop ultrasound imaging systems, has signed a distribution agreement for the European market with Aloka Holding Europe AG (Tokyo, Japan; www.aloka.com), a leading manufacturer and distributor of ultrasound systems.

The agreement names Aloka as Terason's exclusive European distributor for the Terason t3000 ultrasound system. "The same attributes that make Terason ultrasound systems popular with a wide range of clinical specialties in the U.S. and Asia--superior image quality, mobility, and connectivity--make our systems ideal for a broad range of European markets as well,” said Alice Chiang, Ph.D., Teratech president and CEO. "Aloka, with decades of successful experience in the European ultrasound market, is a natural distribution choice. This agreement is an important step to increase our momentum in the European market.”

"We are pleased to be associated with the exciting new technology that Terason has developed, and to have been selected to introduce Terason's Windows-based compact, convertible t3000 ultrasound system to the European market,” said Dr. Stephan Suwald, president, Aloka Holding Europe AG. "We look forward to putting this innovative technology into the hands of clinicians throughout Europe.”





Related Links:
Terason
Aloka
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Ultrasound Needle Guide
Ultra-Pro 3
New
Hospital Bed Mattress Cover
Skin IQ 365

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.